Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Account Payables (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Change in Account Payables for 15 consecutive years, with -$1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables fell 732.33% to -$1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.9 million, a 629.69% increase, with the full-year FY2024 number at -$1.3 million, down 196.5% from a year prior.
  • Change in Account Payables was -$1.7 million for Q3 2025 at Usana Health Sciences, down from $3.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.8 million in Q2 2025 to a low of -$6.9 million in Q2 2021.
  • A 5-year average of -$816000.0 and a median of -$925000.0 in 2023 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: plummeted 3864.94% in 2021, then skyrocketed 2143.02% in 2023.
  • Usana Health Sciences' Change in Account Payables stood at -$6.9 million in 2021, then surged by 101.25% to $86000.0 in 2022, then surged by 2143.02% to $1.9 million in 2023, then decreased by 7.98% to $1.8 million in 2024, then plummeted by 194.76% to -$1.7 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Change in Account Payables are -$1.7 million (Q3 2025), $3.8 million (Q2 2025), and $2.0 million (Q1 2025).